Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 10 , Pages 748-753 , December 2010

Coronary vasoreactivity is not altered in young people with type 1 diabetes

Received 6 February 2009 ,Revised 16 June 2009 ,Accepted 16 June 2009.

References 

  1. Wei M, Gaskill SP, Haffner SM, Stern MP. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care. 1998;21:1167–1172
  2. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H and the WHO Multinational Study Group. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001;44(Suppl. 2):S14–S21
  3. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR. Impairment of coronary vascular reserve and Ach-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes. 1993;42:1017–1025
  4. Nahser PJ, Brown RE, Oskarsson H, Winniford MD, Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilatation in patients with diabetes mellitus. Circulation. 1995;91:635–640
  5. Galderisi M, Capaldo B, Sidiropulos M, D'Errico A, Ferrara L, Turco AA, et al. Determinants of reduction of coronary flow reserve in patients with type 2 diabetes mellitus or arterial hypertension without angiographically determined epicardial coronary stenosis. Am J Hypertens. 2007;20:1283–1290
  6. Akasaka T, Yoshida K, Hozumi T, Tagagi T, Kaji S, Kawamoto T, et al. Retinopathy identifies marked restriction of coronary flow reserve in patients with diabetes mellitus. J Am Coll Cardiol. 1997;30:935–941
  7. Strauer B, Motz W, Vogt N, Schwartzkopff B. Impaired coronary flow reserve in NIDDM. A possible role for diabetic cardiopathy in humans. Diabetes. 1997;46:119–124
  8. Di Carli MF, Bianco-Batles D, Landa ME, Kazmers A, Groehn A, Muzik O, et al. Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation. 1999;100:813–819
  9. Taskiran M, Fritz-Hansen T, Rasmussen V, Larsson HBW, Hilsted J. Decreased myocardial perfusion reserve in diabetic autonomic neuropathy. Diabetes. 2002;51:306–310
  10. Pop-Busui R, Kirkwood I, Schmid H, Marinescu V, Schroeder J, Larkin D, et al. Sympathetic dysfunction in type 1 diabetes. Association with impaired myocardial blood flow reserve and diastolic dysfunction. J Am Coll Cardiol. 2004;44:2368–2374
  11. Pitkanen OP, Nuutila P, Raitakari OT, Ronnemaa T, Koskinen PJ, Iida H, et al. Coronary flow reserve is reduced in young men with IDDM. Diabetes. 1998;47:248–254
  12. Sundell J, Janatuinen T, Ronnemaa T, Raitakari OT, Toikka J, Nuutila P. Diabetic background retinopathy is associated with impaired coronary vasoreactivity in people with type 1 diabetes. Diabetologia. 2004;47:725–731
  13. Caiati C, Montaldo C, Zedda N, Montisci R, Ruscazio M, Lai G, et al. Validation of a new noninvasive method (contrast-enhanced transthoracic second harmonic echo Doppler) for the evaluation of coronary flow reserve. Comparison with intracoronary Doppler flow wire. J Am Coll Cardiol. 1999;34:1193–1200
  14. Dimitrow PP, Galderisi M, Rigo F. The noninvasive documentation of coronary microvascular impairment: role of transthoracic echocardiography. Cardiovasc Ultrasound. 2005;3:18–23
  15. Position Statement of American Diabetes Association . Standards of medical care in diabetes. Diabetes Care. 2009;32:S13–S61
  16. de Simone G, Scalfi L, Galderisi M, Cementano A, Di Biase G, Tammaro P. Cardiac abnormalities in young women with anorexia nervosa. Br Heart J. 1994;71:287–292
  17. de Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Alderman MH. Assessment of left ventricular function by the midwall function shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol. 1994;23:1444–1451
  18. Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P, Poldermans D, et al. for the European Association of Echocardiography Stress echocardiography expert consensus statement – executive summary: European Association of Echocardiography. Eur Heart J. 2009;(3):278–289
  19. Rigo F, Richieri M, Pasanisi E, Cutaia V, Zanella C, Della Valentina P, et al. Usefulness of coronary flow reserve over regional wall motion when added to dual-imaging dipyridamole echocardiography. Am J Cardiol. 2003;91:269–273
  20. Galderisi M, Cicala S, Caso P, De Simone L, D'Errico A, Petrocelli A, et al. Coronary flow reserve and myocardial diastolic dysfunction in arterial systemic hypertension. Am J Cardiol. 2002;90:860–864
  21. Galderisi M. Diastolic dysfunction and diabetic cardiomyopathy. J Am Coll Cardiol. 2006;48:1548–1551
  22. Standl E, Schnell O. A new look at the heart in diabetes mellitus from ailing to failing. Diabetologia. 2002;43:1455–1469
  23. Cortigiani L, Rigo F, Gherardi S, Sicari R, Galderisi M, Bovenzi F, et al. Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. J Am Coll Cardiol. 2007;50:1354–1561
  24. Nitenberg A, Ledoux S, Valensi P, Sachs R, Attali JR, Antony I. Impairment of coronary microvascular dilation in response to cold pressor-induced sympathetic stimulation in type 2 diabetic patients with abnormal stress thallium imaging. Diabetes. 2001;50:1180–1185
  25. Di Carli M, Janisse J, Grunberger G, Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol. 2003;41:1387–1393
  26. Prior JO, Quiñones MJ, Hernandez-Pampaloni M, Facta AD, Schindler TH, Sayre JW, et al. Coronary circulation dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation. 2005;111:2291–2298
  27. Quiñones MJ, Hernandez-Pampaloni M, Schelbert H, Bulnes-Enriquez I, Jimenez X, Hernandez G, et al. Coronary vasomotor abnormalities in insulin-resistant individuals. Ann Intern Med. 2004;140:700–708
  28. Sorensen VR, Mathiesen ER, Clausen P, Flyvbjerg A, Feldt-Rasmussen B. Impaired vascular function during short-term poor glycaemic control in type 1 diabetic patients. Diab Med. 2005;22:871–876
  29. Capaldo B, Galderisi G, Turco AA, D'Errico A, Turco S, Rivellese AA, et al. Acute hyperglycemia does not affect the reactivity of coronary microcirculation in humans. J Clin Endocrinol Metab. 2005;90:3871–3876
  30. Sundell J, Laine H, Nuutila P, Ronnemaa T, Luotolahti M, Raitakari O, et al. The effect of insulin and short-term hyperglycemia on myocardial blood flow in young men with uncomplicated type 1 diabetes. Diabetologia. 2002;45:775–782
  31. Sudhir K, MacGregor JS, Barbant SD. Assessment of coronary conductance and resistance vessel reactivity in response to nitroglycerin, ergonovine and adenosine: in vivo studies with simultaneous intravascular two-dimension and Doppler ultrasound. J Am Coll Cardiol. 1993;21:1261–1268
  32. Scherrer U, Sartori C. Insulin as a vascular and sympathoexcitatory hormone. Implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation. 1997;96:4104–4113

PII: S0939-4753(09)00157-4

doi: 10.1016/j.numecd.2009.06.007

Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 10 , Pages 748-753 , December 2010

Article Tools